Estrogen on TRT: The Definitive Guide

What is estrogen, and why does it matter on TRT?

In men, "estrogen" mostly means estradiol, a hormone the body makes from testosterone. An enzyme called aromatase does the conversion in the testicles, brain, fat, muscle, bone, blood vessels and hair. When testosterone therapy raises testosterone, estradiol usually rises with it. [1], [3]

Men need estradiol. The Endocrine Society's guideline says estradiol is required to prevent gains in body fat and hot flushes, and that testosterone and estradiol together keep up sexual function and bone density. Men born unable to make estrogen show what happens without it: one 24-year-old man with this rare condition had estradiol below 7 pg/mL, had grown to 204 cm because his growth plates never closed, and had very thin bones despite plenty of testosterone. [2], [19]

The amounts are small. A man makes about 35–45 micrograms of estradiol a day, and his blood holds roughly 1/200 as much estradiol as testosterone. Normally about 20% is released directly by the testicles and about 60% starts there one way or another. Testosterone therapy turns down the brain's signal to the testicles, so on treatment a larger share likely comes from conversion elsewhere, especially in fat. [1], [2]

Lab reports can also list "total estrogen", which adds several estrogens together and reads higher than estradiol alone. Mixing the two up is a common source of alarm in forums (see what people report), so this guide uses estradiol throughout. [20]

Estrogen on TRT: the key numbers

This table shows what each major clinical guideline says about estradiol for men on testosterone, checked in September 2026. Most give no number at all.

[4], [2], [15], [5], [21], [22], [8], [23], [24], [25]

No major guideline sets a routine estradiol target for men on TRT. The AUA is the only one with a number, and it applies before treatment: estradiol that stays above 40 pg/mL (about 147 pmol/L) earns a referral to look for another cause. Four bodies (the VA, BSSM, EAU and EAA) warn that aromatase inhibitors are off-label, weakly studied or bad for bone. [4], [5], [22], [21], [23]

Doserly

Estradiol numbers in this guide, on one scale

Estradiol in pg/mL (top scale) and pmol/L (bottom scale). Multiply pg/mL by 3.671 to get pmol/L.

Each bar runs from 0 (left) to 60 pg/mL (right). A solid mark is a guideline number; a dashed mark is a study finding.

AUA: 40 pg/mL (about 147 pmol/L)

Refer to a specialist if estradiol stays above this before treatment starts. A referral line, not a treatment target.

16 pg/mL (about 59 pmol/L)

Fracture link strongest below this (2,639 older Swedish men; observational, not on TRT).

About 10 pg/mL (about 37 pmol/L)

Above this, bone was generally protected; below it, hot flushes were much more common (trials in healthy men with their own hormones switched off).

12–136 pmol/L (about 3–37 pg/mL)

One mass-spectrometry lab's male reference range, from 64 men. Ranges differ by lab and method and describe men not on treatment.

No guideline sets an estradiol target for men on TRT. Standard immunoassays read higher than mass spectrometry in men.

Why don't guidelines set a target?

Because no trial has tested one. Experiments that controlled men's hormones show where estradiol becomes too low: below about 10 pg/mL, bone loss and hot flushes became much more likely. No study has found a level above which men on TRT do worse; breast symptoms, not a number, are what guidelines act on. The AUA's 40 pg/mL line asks for a referral before treatment starts; it is not a treatment goal. [14], [13], [4]

What is a normal estradiol level for men?

It depends on the lab and the method, and a lab reference range describes healthy men who are not on treatment. Using mass spectrometry, one laboratory's male range, traceable to the US Centers for Disease Control and Prevention's reference method, was 12–136 pmol/L (about 3–37 pg/mL), based on 64 men. In 394 very healthy Australian men aged 70 or older, the lowest 2.5% had estradiol below 28 pmol/L (about 7.6 pg/mL). Ranges printed next to standard immunoassay results are different again. [26], [27]

How do the units work?

US labs usually report estradiol in pg/mL (picograms per milliliter); most other countries use pmol/L (picomoles per liter). Estradiol's molecular weight is 272.4, so multiply pg/mL by 3.671 to get pmol/L, or divide pmol/L by 3.671 to get pg/mL. That makes 40 pg/mL about 147 pmol/L, and a UK result of 206 pmol/L about 56 pg/mL. A few labs write ng/L, which is the same number as pg/mL. Testosterone uses other units (ng/dL and nmol/L); the testosterone unit converter switches between those. [28], [29]

What about the testosterone-to-estradiol ratio?

It is popular online but not a validated target. A 2025 review said a testosterone-to-estradiol ratio between 10 and 30 "seems" beneficial, then added that the best value "has not yet been determined". The ratio also changes with the units each number is reported in, and no guideline uses it. [30]

Why does estradiol rise on TRT?

Because more testosterone gives aromatase more to work with. Estradiol follows the testosterone level, and how much a man converts depends on his body fat, his age and the individual. These effects are measured in people. [3], [32]

• Dose and level. In a randomized trial, 103 healthy young and older men had their own hormones switched off and then received one of five weekly enanthate doses for 5 months (25–600 mg; the top doses were research doses, far above treatment). Estradiol rose with the dose. In one practice's records of 178 men on gels, injections or pellets, the testosterone level, not age or body mass index, predicted estradiol. [3], [32]
• Age and body fat. In the same trial, older men converted more: their maximum conversion rate was 40% higher, partly because they carried more body fat. Obesity lowers a man's own testosterone partly through extra conversion to estradiol in fat, as the CUA describes, and the EAU notes that a low-calorie diet lowers estrogens. [3], [15], [21]
• Big differences between men. After a single 250 mg enanthate injection in 21 men with low testosterone, estradiol peaked at the one-week blood draw. In 12 men it tripled on average; in the other 9 it did not rise at any weekly test. [33]
• What the labels report. On AndroGel 1%, estradiol rose within 30 days and stayed higher, but within the normal male range, and the AndroGel 1.62% label says estradiol rose in line with testosterone. In the 84-week Aveed (undecanoate injection) study, "estradiol increased" was listed as a side effect in 4 of 153 men (2.6%) and was one of the reasons some stopped. [12], [34], [35]
• hCG. hCG makes the testicles produce their own testosterone again, and they turn part of it into estradiol. See does hCG raise estradiol?. [8]

Do the form and the injection schedule matter?

Possibly, but only observational studies compare them, and they do not agree on a simple rule.

• Form. In one practice's records, estradiol rose most with injections and gels and least with pellets, but the men were not randomized. [32]
• Route. In 234 men, a weekly subcutaneous (into the fatty layer under the skin) enanthate autoinjector (Xyosted) was linked with lower estradiol than weekly intramuscular (into a muscle) cypionate at similar testosterone levels, but the ester, route and device all differed. When 20 long-term users of undecanoate injections took the same dose both ways in random order, estradiol did not differ between the routes. [36], [37]
• Frequency. Among 263 men, 100 mg weekly and 200 mg every 2 weeks raised estradiol by similar amounts. [7]

No randomized trial has tested whether splitting the same weekly dose into more injections lowers estradiol. The TRT dosage guide covers splitting schedules, and the testosterone level visualizer shows how injection frequency changes the peaks and troughs that estradiol follows.

What does the research show?

Estradiol has clearer effects when it is too low than when it is high. Trials that blocked estradiol in men caused body fat gain, hot flushes, lower sex drive and bone loss. Studies have not shown that high estradiol harms men on TRT beyond breast symptoms, and trials of aromatase inhibitors have not shown a benefit men can feel. [38], [13], [14], [39]

How common is high estradiol on TRT?

It depends on the test and the cut-off, and good data are scarce.

• One US clinic chain. In its records (cohort study), 7,215 of 34,016 men (about 21%; the paper prints 20.2%) had estradiol of 42.6 pg/mL or more on a standard immunoassay. The records mixed men being screened with men on injections, and clinicians prescribed aromatase inhibitors and SERMs "irrespective of blood estradiol levels". [40]
• One US sexual-medicine practice. Of 1,708 men on testosterone or clomiphene, 44 (2.6%) were given anastrozole for estradiol above 60 pg/mL, or 40–60 pg/mL with breast or nipple tenderness. That is the share one practice treated, not the share of men with high estradiol. [41]
• Clinicians disagree. In a survey of 489 members of the International Society for Sexual Medicine (a 22.5% response rate), 54.7% said they monitor estradiol on TRT; 69.4% treat high estradiol with symptoms, 47.7% treat it without symptoms and 14.4% prescribe an estrogen-lowering medicine preventively. Anastrozole starting doses varied widely. [42]

Does high estradiol cause symptoms?

For breast tenderness and growth, it can; for most other complaints, the evidence is thin.

• Breast symptoms are the side effect guidelines tie to estradiol: the AUA and CUA check estradiol when they appear. [4], [15]
• Sex drive. In the Testosterone Trials of older men with low libido, bigger rises in estradiol, as well as testosterone, went with bigger gains in sexual desire and activity, though not in erections. In a clinic chain's records, high estradiol was not linked with low libido. In 126 young men and women, raising estradiol for 2 days had only minor effects on desire. [43], [40], [44]
• Water retention, mood swings and erection problems are often blamed on high estradiol online. We found no study showing that high estradiol causes them in men on TRT, and in the Testosterone Trials estradiol rises were not linked with erectile function (see the symptoms table). [43]

How common is breast growth (gynecomastia) on TRT?

Uncommon in trials, though many trials do not report it.

• Gel labels. On AndroGel 1%, gynecomastia affected 1% of men at 50 mg, 0% at 75 mg and 3% at 100 mg over 180 days, and 2.5% over a 3-year extension. On Testim it was 1% at 50 mg and 0% at 100 mg over 90 days, against 0% on placebo. [12], [45]
• Injections. No gynecomastia occurred in 130 men over 24 weeks of undecanoate injections. [46]
• Guideline reviews. The AUA's evidence review found gynecomastia events in only 3 of its studies; in one gel trial, 2 of the 4 men with it at 180 days had it before treatment. The Endocrine Society calls it uncommon, with weak evidence of a link. [4], [2]
• Missing data. A 2026 review of 30 testosterone trials found that only 17% reported gynecomastia at all, and none graded it. [47]
• Label wording. The older Testopel pellet label says gynecomastia "frequently develops", while current injection labels say it may develop. [48], [49]

What happens when estradiol is too low?

This is where the evidence is strongest, and most of it comes from experiments in healthy men.

• Body fat and sex drive. In 400 healthy men aged 20–50 whose own hormones were switched off for 16 weeks, adding anastrozole to block estradiol showed that estradiol deficiency mainly accounted for gains in body fat, and that low testosterone and low estradiol both lowered sexual function. [38]
• Hot flushes. In the same experiments, hot flushes were reported at 35% of visits when estradiol was blocked and 26% when it was not, and at 38% of visits with estradiol of 5–9.9 pg/mL against 16% at 10–14.9 pg/mL. [13]
• Bone. Spine bone density fell at every testosterone dose when estradiol was blocked; estradiol above 10 pg/mL and testosterone above 200 ng/dL were generally enough to protect bone. In older men given testosterone gel or anastrozole for a year, only the gel improved spine bone density, even though both raised testosterone above 500 ng/dL. [14], [50]
• Blood sugar. Six weeks of anastrozole lowered insulin sensitivity in 17 healthy men. In 29 older men, a year of anastrozole did not change insulin resistance, inflammation or cholesterol. [51], [52]
• Libido on aromatase inhibitors. In a randomized trial of 296 men with infertility, decreased libido was reported by 12.2% on letrozole against 5.4% of controls. [53]
• Long-term links in men not on TRT. In 2,639 older Swedish men, lower estradiol went with more fractures, most strongly below 16 pg/mL. In the Framingham study of 793 older men, 39 had a hip fracture: 11.0 per 1,000 person-years in men with estradiol of 2.0–18.1 pg/mL against 3.9 in men at 34.3 pg/mL or more (3.1 times the risk after adjustment). In pooled community studies using mass spectrometry, very low estradiol (below 5.1 pmol/L, about 1.4 pg/mL) went with higher death rates. These show links, not cause. [54], [55], [56]

Do aromatase inhibitors help men on TRT?

No trial has shown that adding one improves how men on TRT feel or function, and the longest trials in men found bone loss. Only small or short studies have tested one alongside testosterone:

Larger trials used aromatase inhibitors instead of testosterone, in older or heavier men with low testosterone. They raise testosterone reliably, but benefits did not follow:

• Older men, anastrozole, 1 year. In 69 men aged 60 or older, testosterone rose from 319 to 524 ng/dL by month 3 and estradiol fell from 15 to 12 pg/mL. Spine bone density fell (1.121 to 1.102 g/cm²) while it rose on placebo (1.180 to 1.189). A companion report of 88 men found no gain in body composition or strength. [9], [61]
• Older men, anastrozole, 12 weeks. In 37 men aged 62–74, testosterone rose into the young-adult range and estradiol fell from about 26 to 17 pg/mL, but erection scores and quality of life did not change. [62]
• Obese men, letrozole, 6 months. In 42 men, testosterone rose from 8.6 to 21.5 nmol/L, with no physical or psychological benefit. [63]
• Obese men, leflutrozole, 24 weeks. In 271 men, testosterone normalized, but sexual symptoms and body composition did not improve, and spine bone density fell 1.2–2.1% against a 0.7% rise on placebo. [10]
• Pooled trials. A 2022 meta-analysis of 3 randomized trials (118 men) found testosterone about 7 nmol/L higher at 3 months and spine bone density 0.04 g/cm² lower at 6 months. [64]

A 2026 review summed it up: rises in testosterone "did not consistently translate" into better sexual function or performance, and aromatase inhibitors "should not be regarded as general testosterone-restoring or performance-enhancing agents". [39]

Doserly

Spine bone density in two aromatase inhibitor trials in men

Both medicines raised testosterone. Spine bone density fell on the medicine and rose slightly on placebo.

Leflutrozole, 24 weeks (Jones 2023)

271 men with obesity and low testosterone. Change in spine bone density from the start; bars run from −2.5% (left) to +1% (right), with the line at 0.

0.1 mg weekly

−1.24%

0.3 mg weekly

−1.30%

1.0 mg weekly

−2.09%

Placebo

+0.66%

Anastrozole 1 mg daily, 1 year (Burnett-Bowie 2009)

69 men aged 60 or older with low testosterone. Spine bone density in g/cm² at the start (open dot) and after 1 year (arrow); the scale runs from 1.08 to 1.20. Difference between groups: P = 0.0014.

Anastrozole

1.121 to 1.102 g/cm²

Placebo

1.180 to 1.189 g/cm²

Neither trial added the medicine to TRT; both used it instead of testosterone.

Is high or low estradiol on TRT dangerous?

High estradiol on its own has not been shown to harm men on TRT, apart from breast symptoms. The documented harms come from pushing estradiol too low, usually with an aromatase inhibitor: bone loss, body fat gain, hot flushes and lower sex drive. [4], [14], [9], [38]

Are aromatase inhibitors safe for men?

Their long-term safety in men has not been established, and the warnings that exist point to bone.

• Approval and warnings. Anastrozole (Arimidex), letrozole (Femara) and exemestane (Aromasin) are approved only for breast cancer in women after menopause, and each label warns about bone density loss. The anastrozole label also says cholesterol may rise, and reports more heart events from narrowed arteries than with tamoxifen in women who already had heart disease. [11], [65], [66]
• In men. Spine bone loss appeared in the trials above, and in 80 boys with gynecomastia during puberty, anastrozole did no better than placebo. Reported side effects of leflutrozole included raised hematocrit, high blood pressure, higher PSA and headache. [9], [10], [11]
• Guidelines. The VA advises against them in general, and the BSSM calls for close long-term monitoring. [5], [22]

The anastrozole guide covers the medicine in full.

Does estradiol affect heart health on TRT?

Nobody knows for men on TRT. In 501 men with heart failure, both the lowest (below 12.9 pg/mL) and the highest (37.4 pg/mL or more) fifths of estradiol had higher 3-year death rates than the middle (adjusted 3-year survival about 45% and 64%, against 82% in the middle fifth), and pooled community studies link very low estradiol with higher death rates. Neither tested a treatment. The VA and the anastrozole label warn about heart events with aromatase inhibitors in people who already have heart disease, based on data from women with breast cancer. [67], [56], [5], [11]

The largest heart-safety trial of testosterone, TRAVERSE, compared a daily testosterone gel with placebo in about 5,200 men aged 45–80 at high heart risk; it did not test aromatase inhibitors. Heart attack, stroke or cardiovascular death occurred in 7.0% of men on testosterone and 7.3% on placebo (hazard ratio 0.96), 182 and 190 men out of about 2,600 in each group, which met the trial's safety goal. Some problems were more common on testosterone: atrial fibrillation 3.5% vs 2.4%, acute kidney injury 2.3% vs 1.5%, and pulmonary embolism 0.9% vs 0.5%. Its limits: it tested only a gel, men used it for an average of 21.7 months, about 61% stopped their study gel early, and it enrolled men already at high heart risk. The TRT and heart health guide covers it in full. [68], [69]

Who should be especially cautious?

• Men with thin bones, a past fracture or other risks for osteoporosis, before any estrogen-lowering medicine, because every aromatase inhibitor label warns about bone loss. [11], [65], [66]
• Men with heart disease, for the heart-event warnings above. [5], [11]
• Men who want children. Testosterone therapy lowers sperm production, and fertility guidelines list aromatase inhibitors only as an alternative to testosterone, not an add-on. See TRT and fertility. [25]
• Men with a new breast lump, a hard one-sided swelling or nipple discharge. These need a clinician's examination rather than an estrogen test alone. Current US testosterone labels and the EAU list breast cancer in men as a reason not to use testosterone (checked September 2026). [49], [21]
• Drug-tested athletes. Testosterone, aromatase inhibitors and SERMs are prohibited at all times. [18]
• Under-18s. Testosterone and estrogen-lowering medicines for teenagers belong only in specialist care; anastrozole did not help pubertal gynecomastia in boys. [11]
• Women. This guide is written for men. Testosterone for women uses different doses and products; see testosterone therapy for women.

Which medicines and supplements affect estradiol?

• Tamoxifen with anastrozole. Taken together, anastrozole levels fell by 27% in a breast cancer trial, and the US tamoxifen label says the two should not be taken together. [70], [11]
• hCG adds estradiol made in the testicles (see does hCG raise estradiol?). [8]
• Weight-loss medicines. In a small non-randomized study, tirzepatide plus lifestyle changes lowered estradiol more than lifestyle changes alone in men with obesity and low testosterone. See TRT and GLP-1 medicines. [71]
• Supplements sold to "block estrogen" have not been tested for this in men (see supplements).

Bring a complete list of what you take, including supplements, to a pharmacist or prescriber. Checked September 2026.

Is it legal, and is it allowed in sport?

Checked September 2026. Rules differ by country and change often.

• United States. Testosterone and its esters are Schedule III controlled substances. Anastrozole, letrozole and exemestane are prescription medicines approved only for breast cancer in women after menopause, so prescribing them to men is off-label; the raloxifene (Evista) label says it is not recommended in men. [72], [11], [65], [66], [73]
• United Kingdom. Testosterone is a Class C controlled drug. [74]
• Canada. Testosterone is a Schedule IV controlled substance. [75]
• Australia. Testosterone is a Schedule 4 prescription-only medicine. [76]
• Sport. The World Anti-Doping Agency (WADA) prohibits testosterone, aromatase inhibitors and SERMs such as tamoxifen and clomiphene at all times, and its 2027 list, published in September 2026, keeps them all. [18], [77]

What do guidelines say to do about high estradiol?

Start with symptoms, not the number. For breast symptoms on treatment, the AUA watches first, lowers the testosterone dose if testosterone is in the upper normal range, and considers an aromatase inhibitor only when testosterone is low or normal. No guideline recommends treating a high estradiol result in a man without symptoms. This section describes the choices clinicians weigh; it is not a personal plan. [4], [5]

[4], [8], [5], [22], [21], [23], [78], [79]

Should an aromatase inhibitor be added to TRT?

Not routinely: no guideline recommends it, and only the AUA names a situation for it (see the table). The Endocrine Society, the Society for Endocrinology and the CUA do not suggest aromatase inhibitors for men on TRT at all. [4], [2], [8], [15]

When one is prescribed, the AUA rechecks blood tests no sooner than 4 weeks after anastrozole starts, and the anastrozole label suggests considering bone density and cholesterol monitoring. One US practice started anastrozole at 0.5 mg three times a week, off-label, adjusting it to keep estradiol between 20 and 40 pg/mL; it did not report symptoms, bone density or side effects. The anastrozole guide covers the medicine's protocols and evidence. [4], [11], [41]

Does lowering the testosterone dose lower estradiol?

Usually estradiol falls when testosterone falls, which is why the AUA lowers the dose first when on-treatment testosterone is in the upper normal range. No trial has tested a dose cut specifically to lower estradiol, and a lower dose can bring back symptoms of low testosterone. In community threads, some men's estradiol halved with their dose while others' barely moved (see what people report). [4], [3]

What about breast growth (gynecomastia)?

Gynecomastia is growth of the glandular breast tissue, felt as a firm, sometimes tender disc under the nipple; it is different from fat on the chest. Gynecomastia guidelines recommend dealing with the cause and waiting first, medicine only for selected cases, and surgery for long-standing growth. [78], [79]

• Watch first. The AUA says breast symptoms sometimes settle; the European Academy of Andrology (EAA) and Italy's andrology society (SIAMS) recommend waiting and watching recent cases once the cause is dealt with. [4], [78], [79]
• Blocking the receptor worked better than lowering estradiol. In a 48-week trial of 114 men taking bicalutamide, a prostate cancer medicine that often causes breast growth, gynecomastia developed in 73% on bicalutamide alone, 51% with anastrozole added and 10% with tamoxifen added. Anastrozole did not significantly reduce it; tamoxifen did. That was a different situation from TRT, but it matches the anastrozole label's trial in boys, which found no benefit. [80], [11]
• Guidelines disagree on medicines. The EAA says SERMs, aromatase inhibitors and androgens that cannot become estradiol are "not justified in general". SIAMS says medicine "may be considered" in selected unexplained or painful cases. The EAU says DHT "can be useful". In the US, none of these medicines is approved for gynecomastia (checked September 2026), and the raloxifene label says it is not recommended in men. [78], [79], [21], [11], [70], [73]
• Surgery is the EAA's treatment of choice for long-lasting gynecomastia, and SIAMS reserves it for long-standing, fibrous tissue or marked distress. [78], [79]

Doserly

Breast growth over 48 weeks on bicalutamide, by added medicine

Share of men who developed gynecomastia (breast gland growth) in a randomized, double-blind trial.

Bars run from 0% to 100% of men.

Placebo added

73% of men. Bicalutamide alone.

Anastrozole added

51% of men. Lowers estradiol. Not a significant reduction.

Tamoxifen added

10% of men. Blocks the estrogen receptor in breast tissue. Significant reduction.

114 men with prostate cancer on bicalutamide; not men on TRT. Blocking the receptor did more than lowering estradiol.

The tamoxifen guide covers its doses, evidence and risks, including clots, and the TRT side effects guide covers sore nipples alongside other side effects.

How do tests, weight, hCG and supplements affect estradiol?

What is the sensitive estradiol test, and does it matter?

It matters, because the standard test reads high in men. A "sensitive" or "ultrasensitive" estradiol usually means one measured by mass spectrometry (often written LC-MS/MS), which identifies molecules by weight. Standard blood tests use an immunoassay, which detects estradiol with antibodies and struggles at the low levels found in men. Check which method your lab used, because the name on the report varies.

• The Endocrine Society's position statement says estradiol levels in men are "too low to be routinely measured accurately or precisely". [17]
• Readings run high. In 101 healthy men over 40, all five direct immunoassays tested read higher than mass spectrometry, by 6% to 74%, and only mass spectrometry correlated with testosterone and SHBG as expected. [16]
• Low results get missed. In 3,174 European men aged 40–79, a widely used platform immunoassay caught only 13.3% of truly low estradiol results; the authors concluded it may only be suitable for detecting high estradiol. [81]
• Something else gets counted. In more than 6,000 men from three studies, immunoassay results tracked C-reactive protein, a marker of inflammation, while mass-spectrometry results did not, suggesting interference. [82]

No guideline requires the sensitive test for TRT follow-up, but when a decision rests on an estradiol number, the method behind it matters. The TRT blood work guide covers when to draw each test.

Does losing weight lower estradiol?

Yes, in men not on TRT; no study has tested it in men on TRT.

• Pooled studies. A 2013 meta-analysis of 24 studies found that weight loss, by diet or bariatric surgery, lowered estradiol and raised testosterone (about 2.9 nmol/L with a low-calorie diet and 8.7 nmol/L after surgery). A 2026 meta-analysis of 59 surgery studies also found estradiol fell after surgery. [6], [83]
• A diet trial. In 40 frail older men with obesity, diet-led weight loss of about 10% lowered estradiol by about 2.5 pg/mL over a year. [84]
• Medicines. In the tirzepatide pilot described above, estradiol fell further than with lifestyle changes alone. [71]

The obesity-related hypogonadism guide and the TRT and GLP-1 guide cover weight and testosterone together.

Does hCG raise estradiol?

It can. hCG makes the testicles produce their own testosterone, and the testicles turn part of it into estradiol. In the one series of 26 men on TRT plus hCG 500 IU every other day, estradiol did not change significantly, but that study was small and looked back at records. UK Society for Endocrinology guidance checks estradiol after 4 weeks when hCG is used instead of testosterone for fertility, and says a high result may call for a lower hCG dose; it does not endorse combining hCG with testosterone, so no guideline sets an estradiol check for TRT plus hCG. The hCG guide explains the timing. [85], [8]

Do DIM, calcium D-glucarate, zinc or other supplements lower estradiol?

We found no human trial in men that measured estradiol after DIM, calcium D-glucarate, zinc, chrysin or grape seed extract. In the US, supplements are not approved by the FDA for safety or effectiveness (checked September 2026). One man's estradiol read 57 and 59 before, and 57 after, more than three months of daily DIM and calcium D-glucarate. See the supplement guides for DIM, calcium D-glucarate, zinc and grape seed extract. [86], [87]

What are the symptoms of high and low estradiol in men?

Some are well studied; many online "estrogen symptoms" are not.

Many of these symptoms have other causes. In community threads, other explanations (a thyroid problem, a dosing error, a large hCG dose) often turned up once people looked closer. [88], [89], [29]

How long does "crashed" estradiol take to recover?

No study has measured it in men. People use "crashed E2" for estradiol pushed very low, usually by an aromatase inhibitor. The medicines themselves have half-lives of about 50 hours (anastrozole), 2 days (letrozole) and 24 hours (exemestane), but symptoms in community accounts took days to weeks to ease, and one man's repeat test rose from 0 to 20 while he still felt unwell. [11], [65], [66], [90]

What do people on TRT report about estrogen?

Estrogen is one of the most argued-over topics in public TRT forums. The threads below are recent public Reddit discussions, read with their replies; they show what people experience, not how often it happens.

Does a high number always mean symptoms?

No, and that is the most common surprise. One man felt very well six weeks into treatment with an estradiol of 154 pg/mL and testosterone of 1,500 ng/dL; his doctor still advised a lower dose. Another, 13 months in and in the best shape of his life, had no nipple, libido or erection problems at 74. A third had 167 pmol/L at three months with no symptoms and declined the aromatase inhibitor he was offered. [91], [92], [93]

Others do link symptoms to high readings, but the symptoms are often vague. One man at 374 pmol/L had no nipple symptoms but felt tired and anxious after feeling great in his first weeks, and chose a small dose cut and more frequent injections instead of a medicine. [94]

What happens when estradiol is pushed too low?

Accounts of "crashed E2" are among the most vivid in these forums. One man with an estradiol of 43 and no symptoms was started on weekly anastrozole by his clinic; his energy and libido fell from the first dose, his next result was below 5, and he stopped it. Another, whose estradiol had risen from 41 to 61, took a small weekly dose for four weeks and described panic, night sweats, broken sleep and a collapse in libido. [95], [96]

Recovery can be slow. After anastrozole and then exemestane, one man's sensitive estradiol read 0, and he described stiff, painful legs and knees, shoulder pain and anorgasmia; weeks later his repeat result was 20 and he felt only slightly better. [90] Another man felt his erections, mood and joints improve after stopping anastrozole, then found his prescriber wanted to restart it because his estradiol of 66 was outside the lab range, although he had no symptoms. [97] A man who added an over-the-counter "estrogen blocker" to his TRT developed fatigue, anxiety, hot flushes and joint pain within weeks, without a blood test to confirm a fall, and improved after stopping it. [98]

Does anyone feel better on an aromatase inhibitor?

Some do. One man who skipped his prescribed anastrozole saw estradiol rise from 42 to 112 over three months with puffy hands and returning fatigue, and reported more energy and strength within a week of starting it; he also carried a lot of weight around his middle and planned to lose it. [99] Another man on twice-weekly anastrozole had an ultrasensitive result of 40 with poor erections and low mood, and his provider suggested letting estradiol rise a little. [100]

Does lowering the dose or splitting injections work?

Results pull both ways. One man cut cypionate from 100 to 60 mg a week and saw estradiol halve (66 to 33 pg/mL) and felt better, even though his testosterone fell from 731 to 339 ng/dL. [101] Others saw estradiol barely move: a lower dose split into two injections took one man's trough testosterone from 1,010 to 750 ng/dL while estradiol went from 57 to 55 pg/mL, and another man's estradiol stayed near 50 pg/mL after a dose cut that left him with less drive. [102], [103] A third was still at 245 pmol/L (from 298) after 11 weeks on a much lower dose, with nipple tenderness, and his GP suggested pausing to check his baseline hormones and thyroid. [104]

What do breast lumps look like in these threads?

Usually a small, tender lump under one nipple. One man felt a lump months into treatment; an ultrasound found a gland about an inch across that did not change over two weeks, and a mammogram was booked while his clinic advised waiting. [105] Another felt a marble-sized lump after his testosterone rose from about 900–1,000 to 1,500 ng/dL on the same dose. [106] A third, six weeks in, found small lumps but had old photos showing puffy nipples before TRT, and his estradiol (143 pmol/L) was inside his lab's range. [107] A fourth noticed breast fullness within about a week of raising his dose and injecting daily while also taking hCG. [89] Tenderness does not always track the number: one man's sore nipple persisted across estradiol results from the teens to the high 30s, and an early result of 8 on a high anastrozole dose came with poor sexual function and low energy. [108]

How often is the number itself the problem?

Often. One man alarmed by a jump from 90 to 250 found, on checking his reports, that 250 was total estrogen and his estradiol had gone from 32 to about 90. [20] Unit confusion is common: 206 pmol/L sounds high but is about 56 pg/mL, and one man's 165 pmol/L (about 45 pg/mL) sat just above a lab range that ended at 159. [29], [109] Timing and other medicines muddy it further: one man's 206 pmol/L came with 3,000 IU of hCG a week, and another's estradiol of 99 pg/mL came with hCG and a thyroid test (TSH) of 68 while on thyroid replacement. [29], [88]

How can you judge an estradiol story?

Ask: Which test was used, standard or mass spectrometry, and was it estradiol or total estrogen? Which units? When was the blood drawn relative to the last injection? What was testosterone at the same draw? Was hCG, a weight-loss medicine or anything else changed at the same time? Were the symptoms there before TRT? Was the result repeated? And what happened a few months later?

These selected discussions show what people experience and the questions research has not answered. They are not a survey of all men on TRT, a success rate or a substitute for the studies above.

What should you track?

Breast symptoms first, then estradiol when they appear. Routine TRT monitoring under most guidelines is testosterone, hematocrit and, for some men, PSA, not estradiol. Use this summary to prepare questions for your prescriber; it is not a personal testing plan. [2], [4]

[4], [15], [2], [11], [22], [13], [6]

A single estradiol result is one point on a line. Because the test method, the units and the timing all move the number, results from the same lab and method, drawn at a similar point in the injection cycle, say more than any one reading. The TRT blood work guide covers draw timing, and the TRT dose calculator shows what a dose change means in mL and syringe units.

Common questions about estrogen on TRT

Do I need an aromatase inhibitor on TRT?

Most men do not, and no guideline recommends one routinely. The AUA considers one only for persistent breast symptoms with a high estradiol when on-treatment testosterone is low or normal; the VA advises against them in general. In trials, they lowered estradiol and spine bone density without improving how men felt. [4], [5], [9] See what guidelines do.

What estradiol level is too high on TRT?

No guideline sets one. The AUA refers men whose estradiol stays above 40 pg/mL (about 147 pmol/L) before treatment, and on treatment it acts on breast symptoms, not a number. Standard tests read high in men, so the method matters as much as the result. [4], [16] See the key numbers.

Can high estrogen cause erectile dysfunction?

It has not been shown in men on TRT. In the Testosterone Trials, rises in estradiol were not linked with erectile function, and bigger rises went with better sexual desire and activity. Estradiol pushed too low did lower sexual function in controlled experiments. Erection problems have many causes worth checking first. [43], [38] See the symptoms table and the TRT sexual health guide.

Does injecting more often lower estrogen?

No trial has shown it. In 263 men, 100 mg weekly and 200 mg every 2 weeks raised estradiol by similar amounts, and route comparisons conflict. Men in forums report both outcomes. [7], [36], [37] See form and schedule.

Is anastrozole safe long-term?

Not established for men. It is approved only for breast cancer in women, its label warns about bone density loss and higher cholesterol, and a 1-year trial in older men found spine bone loss. The VA notes that no placebo-controlled trial in men has lasted longer than a year. [11], [9], [5] See the risks and the anastrozole guide.

Does DIM lower estrogen on TRT?

We found no trial in men that measured it. One man's estradiol was unchanged after more than three months of daily DIM with calcium D-glucarate, and supplements are not FDA-approved for safety or effectiveness. [87], [86] See supplements.

Is estrogen the same as estradiol on a blood test?

Not quite. Estradiol is the main estrogen and the one guidelines refer to; a "total estrogen" result adds several estrogens together and reads higher. Check which one your report shows, and in which units (pg/mL or pmol/L). [1], [28] See the units.

Glossary

Plain explanations of the medical, lab and research terms used in this guide. Underlined terms in the text link here.

Aromatase

The enzyme that turns testosterone into estradiol. It is found in fat, the brain, bone, muscle, blood vessels and the testicles.

Aromatase inhibitor

A medicine, such as anastrozole, letrozole or exemestane, that blocks the enzyme that turns testosterone into estradiol, so estradiol falls. They are approved only for breast cancer in women, so use in men is off-label.

Bone mineral density

A measure of how much mineral the bones hold, usually checked with a low-dose X-ray scan (DXA). Lower density means weaker bones and a higher fracture risk.

Cohort study (records study)

A study that follows a group of people, or looks back at their records, without assigning treatments. It can show links but not prove that one thing caused another.

Controlled trial

A study that compares people who receive a treatment with a similar group who do not, often receiving a placebo instead. Randomly assigning people to each group makes the comparison fairer.

DHT (dihydrotestosterone)

A stronger form of testosterone made in some tissues. It cannot be turned into estradiol.

Estradiol (E2)

The main form of estrogen. In men it is made mostly from testosterone, so it rises when testosterone rises.

Clinical guideline

Recommendations written by a medical society or health system, based on its review of the evidence and expert judgment. Different guidelines can reach different conclusions.

Gynecomastia

Growth of breast tissue in men, often tender at first. It is linked to a higher estrogen-to-testosterone balance.

Half-life

The time it takes for the level of a substance in the blood to fall by half. For anastrozole it is about 50 hours. It is not the same as how long an effect lasts.

Hazard ratio

A measure comparing how often an event happens over time in two groups. A hazard ratio of 1 means no difference; 0.96 means about 4% lower in the first group.

hCG (human chorionic gonadotropin)

A hormone medicine that acts like LH, telling the testicles to make their own testosterone. It is sometimes added to TRT to keep the testicles working.

Hot flush (hot flash)

A sudden feeling of heat, often with sweating and a flushed face. In men it is driven mainly by low estradiol.

Immunoassay

A common lab method that uses antibodies to detect a hormone. For estradiol at men's low levels, it tends to read high.

Intramuscular (IM)

Injected into a muscle. Most testosterone cypionate and enanthate is given this way.

Product label (prescribing information)

The official document approved by a medicines regulator for a product, describing its approved uses, doses, warnings and monitoring. In the UK it is called the summary of product characteristics.

Mass spectrometry (LC-MS/MS)

A lab method that identifies molecules by their weight. It measures men's estradiol more accurately than an immunoassay and is what "sensitive" estradiol tests usually use.

Meta-analysis and systematic review

A systematic review gathers all studies on a question in a planned way. A meta-analysis combines their results statistically.

Off-label use

Prescribing an approved medicine for a use, dose or group of people that its label does not cover. It is legal for prescribers but means the regulator has not reviewed evidence for that use.

pg/mL and pmol/L

The two units for estradiol. Multiply pg/mL by 3.671 to get pmol/L: 40 pg/mL is about 147 pmol/L. ng/L is the same number as pg/mL.

Placebo

A dummy treatment with no active ingredient, used as a comparison in studies.

Reference range

The spread of results a lab expects in healthy people, printed next to your result. It differs between labs and methods and is not a treatment target.

SERM (selective estrogen receptor modulator)

A tablet, such as tamoxifen, raloxifene, clomiphene or enclomiphene, that blocks estrogen's action in some tissues and mimics it in others. Tamoxifen blocks it in breast tissue without lowering estradiol.

SHBG (sex hormone-binding globulin)

A blood protein that carries testosterone and estradiol. Hormone bound to it is not immediately available to tissues.

Subcutaneous (SC)

Injected into the fatty layer just under the skin. Xyosted is given this way, and some prescribers use this route for other testosterone injections.

Testosterone-to-estradiol ratio

Testosterone divided by estradiol. It is discussed online, but no guideline uses it, no best value has been established and it changes with the units used.

TRT (testosterone replacement therapy)

Prescribed testosterone, by injection, gel or other forms, for men with low testosterone. It switches off the brain's LH and FSH signals.

WADA

The World Anti-Doping Agency, which publishes the list of substances banned in sport. Testosterone, aromatase inhibitors and SERMs are banned at all times.

How this guide was researched

This guide is built from a thorough review of the sources cited throughout it: clinical guidelines and position statements from 12 medical bodies, product labels, published clinical trials and studies, lab-method comparisons and regulatory documents. We also reviewed public online forums where men on TRT describe their own estradiol results.

The guide cites 109 sources, including 42 original studies in people, 14 clinical guidelines and position statements, 12 product labels and 25 public community discussions. Each type of source answers a different question. Guidelines and labels show what clinicians are told to do. Trials and studies show what was measured. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labeled by source type.

How this guide was made

Research and drafting were AI-assisted. Every cited source was checked against the original, and the guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.

This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.

Explore the sources